Menstrual Cycle-induced Pain, Fatigue and Anxiety in Women Suffered From COVID-19

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Total Enrollment

180 participants

Study Classification

OBSERVATIONAL

Study Start Date

2021-05-18

Study Completion Date

2021-06-01

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The effects of COVID-19 on body systems and functions are still being investigated. ACE 2, which plays a key role in the entry of the COVID-19 virus into the cell, is also highly expressed in the ovary, uterus, vagina, and placenta in the female genital system, which can also pose a risk to female reproductive health. The aim of this study is to evaluate menstrual cycle-induced pain, fatigue and anxiety in women who suffered from COVID-19.

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

Effects of Pilates Exercises Applied With Face-to-Face and Telerehabilitation on Menstrual Pain

NCT06530381

Menstrual Pain

COMPLETED NA

Menstrual Cycle Characteristics of Healthcare Professionals

NCT04413058

Menstrual Irregularity Covid 19

COMPLETED

Menstrual Cycle Phases on Recovery and Cognitive Function

NCT03708692

Menstrual Cycle Cognitive Function Recovery +1 more

COMPLETED

Postoperative Recovery Index, Patient Expectations and Satisfaction With Prenatal Care Instrument in Pregnant Patients With COVID-19

NCT04389515

COVID-19 Prenatal Care Postoperative Care

UNKNOWN

Effects of Menstrual Cycle on Preoperative Anxiety

NCT03708679

Menstrual Cycle Perioperative Hypertension Anxiety

COMPLETED

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

The effects of COVID-19 on body systems and functions are still being investigated. ACE 2, which plays a key role in the entry of the COVID-19 virus into the cell, is also highly expressed in the ovary, uterus, vagina, and placenta in the female genital system, which can also pose a risk to female reproductive health. It has been examined that menstruation volume decreased or cycle lengthened in one-fifth of women who had COVID-19, and this condition was more intense in those who had severe COVID-19. Studies have shown that the possible effects of COVID-19 on the female genital system often remain theoretical hypotheses. In the literature, there was no study in which menstrual dysfunctions and secondary problems caused by the state of inactivity entering our lives during pandemic were discussed in a wide spectrum of women who had COVID-19. Therefore the aim of this study is to evaluate menstrual cycle-induced pain, fatigue and anxiety in women who suffered from COVID-19.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Menstrual Problem Covid19 Fatigue

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

COHORT

Study Time Perspective

OTHER

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

A survey of 60 questions was created through the internet-based 'Google Forms surveys' site.

The following tests will be used together with the survey;

* Menstrual Symptom Questionnaire
* Fatigue Severity Scale
* Short Form Of Coronavirus Anxiety Scale

Intervention Type OTHER

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Being between the ages of 18 and 45,
* PCR test result positive confirmed having COVID-19 infection,
* Women had at least one period of Menstrual cycle after COVID-19
* Being an Internet connection,
* To be able to speak and write in Turkish.

Exclusion Criteria

* To be in the premenaposual/postmenopausal period (to be in the transition period to menopause or in the period after menopause.)
* Having insufficient co-operation.

Minimum Eligible Age

18 Years

Maximum Eligible Age

45 Years

Eligible Sex

FEMALE

Accepts Healthy Volunteers

No